Washington, DC Principal Nick Matich was quoted in Law360's article discussing the Biden administration's proposal to seize drug patents if the prices of the medicines are deemed unreasonable and the inevitable legal pushback. Certain legal experts told Law360 that the new framework is a clear case of government overreach and will spur legal challenges. According to Nick, the proposed framework is a mistake that would deter both the biotech industry from collaborating with federal agencies and universities from using government grants.
The full article can be found here.